Overview

Sublingual Versus Intranasal Administration of Dexmedetomidine for Sedation of Children Undergoing Dental Treatment

Status:
Completed
Trial end date:
2020-08-10
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess the efficacy of Dexmedetomidine drug either used sublingually or intranasally in managing healthy children during dental treatment
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Nourhan M.Aly
Collaborator:
Alexandria University
Treatments:
Dexmedetomidine